APA Цитирование

Zhou, L., Mudianto, T., Ma, X., Riley, R., & Uppaluri, R. (2019). Targeting EZH2 enhances antigen presentation, antitumor immunity and circumvents anti-PD-1 resistance in head and neck cancer. Clin Cancer Res.

Chicago-стиль цитирования

Zhou, Liye, Tenny Mudianto, Xiaojing Ma, Rachel Riley, and Ravindra Uppaluri. "Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer." Clin Cancer Res 2019.

MLA-цитирование

Zhou, Liye, et al. "Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer." Clin Cancer Res 2019.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.